A/Prof Ee is an academic GP, Associate Professor (Cancer Survivorship and Primary Care) at Flinders University, Supportive Care GP at Chris O’Brien LIfehouse Cancer Center, and incoming Director of the Primary Care Collaborative Cancer Clinical Trials group (PC4). Her research focusses on the role of primary care in cancer survivorship, reducing health inequity in culturally and linguistically diverse populations and increasing access to care through patient navigation, and on the intersection between cardiometabolic and women’s reproductive health and cancer survivorship.

Professor Elisabeth Elder is a specialist breast surgeon at the Westmead Breast Cancer Institute and privately through Specialist Services at Lakeview Private Hospital.

Elisabeth is a surgeon at the forefront of the developing field of oncoplastic breast surgery; developing techniques that concentrate on achieving not only the best possible outcome for a woman’s breast cancer but also an excellent cosmetic outcome.

Elisabeth is one of the surgeons at the forefront of developing oncoplastic surgical techniques, which means that in appropriate cases she concentrates on a good cosmetic outcome as well as treating her patient’s cancer.

Oncoplastic surgery combines breast cancer surgery with plastic surgery. The combination of cosmetic and oncological treatments gives women more treatment options. For example Elisabeth might take out a cancer and do a breast lift or reduction as part of the same operation. For patients who need a mastectomy, Elisabeth offers a wide range of reconstructive options, including implant based reconstruction (often in combination with nipple sparing mastectomy) and tissue based reconstruction in collaboration with her plastic surgical colleagues.

Dr Anna Singleton (she/her) is an NHMRC Emerging Leadership Fellow and Senior Research Fellow at the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW. Anna has a background in psychology (PhD Dec 2021, MSc Experimental Psych; BSc Hons I Psych) and her research aims to co-design and implement scalable and accessible digital health strategies to improve health outcomes for people living with and beyond cancer.

Anna has been awarded >$5.9M in research funds and awards (>$2.3M as CIA/B) and published >40 peer-reviewed manuscripts, including high-impact journals like theJournal of Clinical Oncology (IF 45.3).Anna was awarded the 2023 NSW Premier’s Award for Outstanding Early Career Researcher and was named a top 25 Brilliant Woman in Digital Health in Australia by TelstraHeath (2022). The same year, Anna’s EMPOWER-SMS clinical trial won the Consumer Involvement Award at the Australian Clinical Trials Alliance Trial of the Year Awards. This trial found that a health and wellness support program delivered via text messages was acceptable, useful and engaging for breast cancer survivors.

Anna is now expanding this work by leading a national multi-centre trial in primary care to help more people across Australia. Anna also holds many leadership positions, including the co-chair of the Primary Care Collaborative Cancer Clinical Trials group Survivorship Engine Room and Topic Editor of Frontiers in Digital Health.

Yvonne completed her general medical training in Western Australia before moving east to the Peter MacCallum Cancer Institute in Victoria to complete her training in radiation oncology. The offer of a fellowship in breast cancer at the Breast Cancer Institute, Westmead Hospital saw her move to Sydney, and this was followed by a position as a consultant radiation oncologist at the Prince of Wales Hospital in Randwick then a clinical fellowship at Massachusetts General Hospital. On returning to Perth, she began working as a consultant radiation oncologist at Royal Perth Hospital and joined GenesisCare in 2011.

Yvonne is the Medical Director for GenesisCare WA and the WA Representative to the CLF (Clinical Leaders Forum). She also Chairs the GenesisCare Breast Expert Advisory Group has been a member of the RANZCR Economics and Workforce Committee. As Adjunct Associate Professor at Curtin University (Dept of Health Sciences) and conjoint lectureships at ECU and UWA, she continues her work in exercise implementation, value-based healthcare, patient navigation and innovative RT research. Clinically, Yvonne treats predominantly breast, skin, upper gastro-intestinal and haematological cancers.

With a strong interest in clinical research and working as an advocate for cancer patients, Yvonne believes in making exercise a part of treatment for all cancer patients, and exploring new ways of improving the patient’s cancer journey.

Blake Henderson is a senior audiologist and former audiology trainer working for Amplifon, Western Australia. He has fifteen years of experience in the industry, and for his outstanding contributions in the industry for supervision of students and graduate interns, was recognised with the inaugural Outstanding Supervisor Award from Audiology Australia in 2023.

Associate Professor Krish Karthigasu is a locally trained Gynaecologist having worked in Perth, England, Melbourne and Sydney with training in advanced endoscopic surgery. He is a Clinical Associate Professor in the Department of Women’s and Infants Health in the University of Western Australia and has been Head of the Gynaecology Endoscopy Department at King Edward Memorial Hospital since 2007, having set up the unit in conjunction with Ray Garry in 2002. He is on the executive of the Anatomy of Complications workshop and a previous Board member of AGES. He works in the private sector performing advanced endoscopic surgery as well as fertility treatment at Fertility Specialists South. His interests include surgical education, endometriosis and fertility.

Dr Scott White is a Consultant Obstetrician and Maternal Fetal Medicine Specialist, having completed training in obstetrics and gynaecology in Western Australia before completing fellowships in Maternal Fetal Medicine in Perth and London. He returned to King Edward Memorial Hospital in Perth in 2016. His clinical interests include preterm birth prevention, complex multiple pregnancy, prenatal diagnosis, and fetal therapy. Dr White completed a PhD in genetic epidemiology in 2017 and was appointed as Senior Lecturer in Maternal Fetal Medicine at The University of Western Australia in 2019. He maintains active research projects in areas such as preterm birth prevention, perinatal epidemiology, and clinical trials in obstetrics and fetal medicine. Dr White is a Councillor of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, serving on several state and national committees including as Deputy Chair of the Women’s Health Committee. He was recently appointed as Associate Editor of the Australian and New Zealand Journal of Obstetrics and Gynaecology.

Sam is a specialist GP in Perth, with specific interests in mental health, eating disorders, ADHD, palliative care and chronic disease. He is particularly passionate about mental health, and has obtained completed Focussed Psychological Strategies (FPS) training, as well as experience in a range of mental health services, including inpatient and outpatient teams, public and private hospital settings, and Sam is an RACGP registrar supervisor and hopes to be part of the first group of WA GPs to undertake specialised ADHD training to diagnose and prescribe treatment, as part of WA’s new ADHD reforms.

Professor Vlado Perkovic is the Provost and Scientia Professor at the University of New South Wales in Sydney, Australia, and was previously the Dean of the Faculty of Medicine & Health at UNSW. He is a Nephrologist and a leading clinical trialist in Nephrology. His research focuses on preventing the progression of kidney disease, and its complications. He has led the Steering Committees of a large number of ground-breaking international clinical trials including FLOW, APPLAUSE, DUPLEX, PROTECT, CREDENCE, TESTING, ASCEND, CARMELINA and other, and leads several that are ongoing.He has received several international awards and is a Fellow of the Australian Academy of Health and Medical Sciences. He serves on the Editorial Board of the New England Journal of Medicine, and is a Highly Cited Researcher (Clarivate, top 0.1% of cited authors).

Dr Emilie Staehr is an Adelaide-based GP with a special interest in mental health, ADHD, and women’s health. A Fellow of the RACGP since 2012, she is the Development Manager of May Medical and the Program Manager, Clinical Lead, and author of May Health’s Adult ADHD Multidisciplinary Group Treatment Programs. Her current focus is on improving systems of care for adults with ADHD and promoting psychologically informed, whole-person approaches to mental health in general practice. Emilie draws on both clinical expertise and lived experience of ADHD in her work, and regularly delivers talks to health professionals, patient groups, and public forums. She has previously been a clinical lecturer at the University of Adelaide.

Carmen is an NHMRC Emerging Leadership Fellow at the National Centre for Youth Substance Use Research. She is passionate about understanding why young people start using substances and dedicated to advance public health through her research. She leads a research program focused on the etiology of youth vaping and drug use, using social media data for surveillance to track trends and tackle emerging challenges.

Carmen is also interested in exploring the disparities in substance use in low- and middle-income countries where she aims to deepen her understanding of substance use patterns and develop effective preventative initiatives, striving to create equitable solutions that address the unique challenges faced in these region.

Dr Ji Moon is a respiratory staff specialist at St Vincent’s Hospital Sydney. Dr Moon has a special interest in lung cancer care. He runs lung nodule clinic and chairs lung nodule MDT and is an active member of lung cancer MDT at St Vincent’s Hospital. He regularly performs bronchoscopy for lung cancer diagnosis and staging. He is currently working to expand bronchoscopy service at St Vincent’s Hospital to improve diagnostic accuracy of early-stage lung cancer.